Press release
World-leading expertise from the University of Dundee’s Centre for Targeted Protein Degradation (CeTPD) will contribute to a new, global effort to tackle some of the most significant challenges posed by cancer.
Press release
World-leading expertise from the University of Dundee’s Centre for Targeted Protein Degradation (CeTPD) will contribute to a new, global effort to tackle some of the most significant challenges posed by cancer.
News
A one day symposium for the Scottish cryo-EM community took place on 30 November 2023
News
On the 10th anniversary of the San Francisco Declaration on Research Assessment (DORA), six panellists reviewed the initiative's impact on the way research is assessed
Press release
A study that could lead to the development of new treatments for people living with Parkinson’s disease has launched at the University of Dundee.
Press release
Researchers at the University of Dundee have thanked members of the public who funded the purchase of new technology that could lead to new treatments for Parkinson’s disease.
News
Chiara Maniaci has become the latest MRC PPU group leader and has now opened her laboratory.
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
News
Parkinson’s UK leadership team and people affected by the disease visited the University of Dundee to meet with local researchers to get an overview of the work that they do.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
News
UFM1 is a ubiquitin-like protein conjugated to ribosomes and is important for secretory protein biogenesis and endoplasmic reticulum homeostasis.
Feature
Early career researchers in the School have received support from the Scottish Universities Life Sciences Alliance (SULSA) to establish new life sciences networks by providing funds towards the running of a network event.
News
The Medical Research Council has invested £200,000 in a new national network which will help scientists overcome barriers to working in interdisciplinary science
Press release
All roads lead west for a University of Dundee scientist who is using pedal power to fund research into Parkinson’s disease.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
Mutations in PINK1 are the second most frequent cause of autosomal recessive early-onset Parkinson’s disease.
Press release
Scientists at the University of Dundee and Harvard Medical School have identified the key targets of an enzyme that play a critical role in protecting the brain against the development of Parkinson’s disease.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
News
Seven new papers have been published this month in The Biochemical Journal, representing a major collaboration between multiple groups at the Francis Crick Institute in London, University College London and The University of Dundee.